Educational Physiotherapy in Haemophilia

July 6, 2016 updated by: Real Fundación Victoria Eugenia

Effectiveness of an Educational Physiotherapy and Home Exercises Program in Adult Patients With Hemophilia: A Randomized Clinical Trial

Although arthropathy is a serious problem in patients with hemophilia due to the associated morbidity and incapacity, to the best of the investigators knowledge, no studies have looked at the effect of educational physiotherapy for its clinical improvement.

This contribution presents the results of educational physiotherapy program applied for 15 weeks with home exercises - in patients with hemophilic arthropathy. After treatment, experimental group showed improved a significant reduction of pain, and best quality of life al illness behaviour. During treatment no patient showed elbow haemarthrosis, which underlines the safety of this physiotherapy program.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Patients diagnosed with hemophilia A or B
  • Patients over 18 years
  • Patients with hemophilic arthropathy with at least 1 involved joint (elbow, knee or ankle)
  • having signed the informed consent document.

Exclusion Criteria:

  • Patients diagnosed with other congenital bleeding disorders (i.e. von Willebrand disease)
  • Patients who developed antibodies to FVIII or FIX (inhibitors)
  • Those not able to ambulate as a result of hemophilic arthropathy or any other disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
The patients in experimental group received 60-minute educational sessions every two weeks about the pathophysiology of hemophilia, clinical manifestations, postural advice and prevention advice to avoid recurrent bleeding. Likewise, doubts on the clinical progress of hemophilic arthropathy, functional limitations and management of joint pain were resolved. In parallel with the educational sessions, patients followed a 15-week home exercise program performed once a day, 6 days a week. The program included muscle stretching exercises; isometric exercises; proprioceptive exercises on one leg with visual support; and a 20-minute walk. Low-intensity exercises with 20-25 repetitions were included.
20 patients with hemophilia were randomly allocated to an educational intervention or to a control group. The educational intervention was performed every two weeks during 15-week and home exercises were performed once a day, 6 days a week, in the same time
No Intervention: Control group
The patients in the control group did not receive any educational sessions and did no exercise at all at home.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline physical condition of joints after treatment and at 6 months
Time Frame: Screening visit, within the first seven days after treatment and after six months follow-up visit
The physical condition of joints was assessed using the Gilbert scale that measures swelling, muscle atrophy, joint crepitus, range of motion, axial deformity and instability. Scores range from 0 to 12 (0 represents no joint injury and 12 represents maximum joint deterioration).
Screening visit, within the first seven days after treatment and after six months follow-up visit
Change from baseline joint pain after treatment and at 6 months
Time Frame: Screening visit, within the first seven days after treatment and after six months follow-up visit
Joint pain was assessed using the Visual Analog Scale (VAS), with scores ranging from 0 (no pain at all) to 10 (the worst pain imaginable by the patient).
Screening visit, within the first seven days after treatment and after six months follow-up visit
Change from baseline perception of the quality of life after treatment and at 6 months
Time Frame: Screening visit, within the first seven days after treatment and after six months follow-up visit
The Haemophilia A-36 questionnaire was used to assess the perception of the quality of life. This questionnaire consists of 36 items that assess 9 domains (physical health, daily activities, joint damage and pain, treatment satisfaction, treatment difficulties, emotional functioning, mental health and social relationships).
Screening visit, within the first seven days after treatment and after six months follow-up visit
Change from baseline illness behavior after treatment and at 6 months
Time Frame: Screening visit, within the first seven days after treatment and after six months follow-up visit
To assess illness behavior, patients completed the Illness Behavior Questionnaire (IBQ). This scale consists of 62 items and 8 domains (hypochondriasis, disease conviction, psychological vs. somatic perception of illness, affective inhibition, affective disturbance, denial and irritability).
Screening visit, within the first seven days after treatment and after six months follow-up visit
Change from baseline frequency of bleedings after treatment and at 6 months
Time Frame: Screening visit, within the first seven days after treatment and after six months follow-up visit
The frequency of bleeding is measured with a record which complete the patients, where they indicate the incidence of hematomas and hemarthrosis during the treatment and follow-up.
Screening visit, within the first seven days after treatment and after six months follow-up visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiological joint deterioration
Time Frame: Screening visit
All patients had an assessment of radiological joint deterioration using the Pettersson scale. This scale, with scores ranging from 0 (a normal joint) to 13 (maximum joint deterioration), is the most widely used to assess joint degeneration produced by hemophilic arthropathy. The evaluation of radiological joint damage was done at the beginning of the study.
Screening visit
Age
Time Frame: Screening visit
Age of patients included in the study
Screening visit
Weight
Time Frame: Screening visit
Weight of the patients
Screening visit
Height
Time Frame: Screening visit
Height of patients
Screening visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

October 1, 2012

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

June 30, 2016

First Submitted That Met QC Criteria

July 6, 2016

First Posted (Estimate)

July 7, 2016

Study Record Updates

Last Update Posted (Estimate)

July 7, 2016

Last Update Submitted That Met QC Criteria

July 6, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Haemophilia

Clinical Trials on Educational physiotherapy group

3
Subscribe